Neutropenia occurrence and predictors of reduced chemotherapy delivery: results from the INC-EU prospective observational European neutropenia study

Author： Pettengell Ruth  

Publisher： Springer Publishing Company

ISSN： 0941-4355

Source： Supportive Care in Cancer, Vol.16, Iss.11, 2008-11, pp. : 1299-1309

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pegfilgrastim: A Review of its Use in Chemotherapy-Induced Neutropenia

By Frampton James E.   Keating Gillian M.  

American Journal of Cancer, Vol. 4, Iss. 4, 2005-01 ,pp. : 255-274

Adis International

Access to resources Recommend Favorite

Prevention of chemotherapy-induced neutropenia by special honey intake

By Zidan Jamal   Shetver Lika   Gershuny Anthony   Abzah Amira   Tamam Sigalit   Stein Moshe   Friedman Eitan  

Medical Oncology, Vol. 23, Iss. 4, 2006-12 ,pp. : 549-552

Humana Press, Inc

Access to resources Recommend Favorite

A phase II double-blinded study to evaluate the efficacy of EW02 in reducing chemotherapy-induced neutropenia in breast cancer

By              

Oncology Letters, Vol. 10, Iss. 3, 2015-01 ,pp. : 1793-1798

Spandidos Publications

Access to resources Recommend Favorite

Real-time broad-range PCR versus blood culture. A prospective pilot study in pediatric cancer patients with fever and neutropenia

By Ammann Roland   Zucol Franziska   Aebi Christoph   Niggli Felix   Kühne Thomas   Nadal David  

Supportive Care in Cancer, Vol. 15, Iss. 6, 2007-06 ,pp. : 637-641

Springer Publishing Company

Access to resources Recommend Favorite

Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk-index score

By Uys Almarie  

Supportive Care in Cancer, Vol. 12, Iss. 8, 2004-08 ,pp. : 555-560

Springer Publishing Company

Access to resources Recommend Favorite